Registro:

Referencias:

• Alvarez, V.E., Niemirowicz, G.T., Cazzulo, J.J., The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death (2012) Biochim Biophys Acta, 1824, pp. 195-206
• Alvarez, V.E., Niemirowicz, G.T., Cazzulo, J.J., Metacaspases, autophagins and metallocarboxy-peptidases: Potential new targets for chemotherapy of the trypanosomiases (2013) Curr Med Chem, 20, pp. 3069-3077. , Review
• Amin, D., Cornell, S.A., Gustafson, S.K., Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis (1992) J Lipid Res, 33, pp. 1657-1663
• Assíria Fontes Martins, T., de Figueiredo Diniz, L., Mazzeti, A.L., Benznidazole/itracon-azole combination treatment enhances anti-Trypanosoma cruzi activity in experimental Chagas disease (2015) PLoS One, 10, p. e0128707
• Babokhov, P., Sanyaolu, A.O., Oyibo, W.A., A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis (2013) Pathog Glob Health, 107, pp. 242-252
• Barrera, P., Sülsen, V.P., Lozano, E., Natural sesquiterpene lactones induce oxidative stress in Leishmania mexicana (2013) Evid Based Complement Alternat Med, 2013, p. 163404
• Baum, S.G., Wittner, M., Nadler, J.P., Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi (1981) Proc Natl Acad Sci U S A, 78, pp. 4571-4575
• Benaim, B., Garcia, C.R., Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review (2011) Trop Biomed, 28, pp. 471-481
• Benaim, G., Paniz Mondolfi, A.E., The emerging role of amiodarone and dronedarone in Chagas disease (2012) Nat Rev Cardiol, 9, pp. 605-609
• Benaim, G., Hernandez-Rodriguez, V., Mujica-Gonzalez, S., In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile (2012) Antimicrob Agents Chemother, 56, pp. 3720-3725
• Benaim, G., Casanova, P., Hernandez-Rodriguez, V., Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy (2014) Antimicrob Agents Chemother, 58, pp. 2295-2303
• Brener, Z., Cançado, J.R., Galvão, L.M., An experimental and clinical assay with ketocon-azole in the treatment of Chagas disease (1993) Mem Inst Oswaldo Cruz, 88, pp. 149-153
• Brengio, S., Belmonte, S., Guerreiro, E., The sesquiterpene lactone dehydroleucodine (DhL) affects the growth of cultured epimastigotes of Trypanosoma cruzi (2000) J Parasitol, 86, pp. 407-412
• Bryson, K., Besteiro, S., McGachy, H.A., Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 response (2009) Infect Immun, 77, pp. 2971-2978
• Buckner, F.S., Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections (2008) Adv Exp Med Biol, 625, pp. 61-80
• Burtoloso, A.C., de Albuquerque, S., Furber, M., Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors (2017) PLoS Negl Trop Dis, 11, p. e0005343
• Campos-Salinas, J., Cabello-Donayre, M., García-Hernández, R., A new ATP-binding cassette protein is involved in intracellular haem trafficking in Leishmania (2011) Mol Microbiol, 79, pp. 1430-1444
• Caputto, M.E., Fabian, L.E., Benítez, D., Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents (2011) Bioorg Med Chem, 19, pp. 6818-6826
• Chakraborti, S., Das, L., Kapoor, N., Curcumin recognizes a unique binding site of tubulin (2011) J Med Chem, 54, pp. 6183-6196
• Chatelain, E., Chagas disease drug discovery: Toward a new era (2015) J Biomol Screen, 20, pp. 22-35
• Chawla, B., Madhubala, R., Drug targets in Leishmania (2010) J Parasit Dis, 34, pp. 1-13
• Ciccarelli, A., Araujo, L., Batlle, A., Effect of haemin on growth, protein content and the antioxidant defence system in Trypanosoma cruzi (2007) Parasitology, 134, pp. 959-965
• Ciccarelli, A.B., Frank, F.M., Puente, V., Antiparasitic effect of vitamin B12 on Trypanosoma cruzi (2012) Antimicrob Agents Chemother, 56, pp. 5315-5320
• Cupello, M.P., Souza, C.F., Buchensky, C., The heme uptake process in Trypanosoma cruzi epimastigotes is inhibited by heme analogues and by inhibitors of ABC transporters (2011) Acta Trop, 120, pp. 211-218
• Dc-Rubin, S.S., Schenkman, S., Trypanosoma crWuzi trans-sialidase as a multifunctional enzyme in Chagas' disease (2012) Cell Microbiol, 14, pp. 1522-1530
• Fernandes Rodrigues, J.C., Concepcion, J.L., Rodrigues, C., In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: Antiproliferative, biochemical, and ultrastructural effects (2008) Antimicrob Agents Chemother, 52, pp. 4098-4114
• Ferreira, R.S., Simeonov, A., Jadhav, A., Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors (2010) J Med Chem, 53, pp. 4891-4905
• Frasch, A.P., Carmona, A.K., Juliano, L., Characterization of the M32 metallocarboxypep-tidase of Trypanosoma brucei: Differences and similarities with its orthologue in Trypanosoma cruzi (2012) Mol Biochem Parasitol, 184, pp. 63-70
• Freire-de-Lima, L., Ribeiro, T.S., Rocha, G.M., The toxic effects of piperine against Trypanosoma cruzi: Ultrastructural alterations and reversible blockage of cytokinesis in epimastigote forms (2011) Parasitol Res, 102, pp. 1059-1067
• Galaka, T., Ferrer Casal, M., Storey, M., Antiparasitic activity of sulfur- and fluorine-containing bisphosphonates against trypanosomatids and apicomplexan parasites (2017) Molecules, 22 (1), p. 82
• Heby, O., Persson, L., Rentala, M., Targeting the polyamine biosynthetic enzymes: A promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis (2007) Amino Acids, 33, pp. 359-366
• Huynh, C., Yuan, X., Miguel, D.C., Heme uptake by Leishmania amazonensis is mediated by the transmembrane protein LHR1 (2012) PLoS Pathog, 8, p. e1002795
• Jiang, Z., Zhou, Y., Using bioinformatics for drug target identification from the genome (2005) Am J Pharmacogenomics, 5, pp. 387-396. , Review
• Jimenez, V., Kemmerling, U., Paredes, R., Natural sesquiterpene lactones induce programmed cell death in Trypanosoma cruzi: A new therapeutic target (2014) Phytomedicine, 21, pp. 1411-1418
• Jimenez-Ortiz, V., Brengio, S.D., Giordano, O., The trypanocidal effect of sesquiterpene lactones helenalin and mexicanin on cultured epimastigotes (2005) J Parasitol, 91, pp. 170-174
• Karioti, A., Skaltsa, H., Kaiser, M., Trypanocidal, leishmanicidal and cytotoxic effects of anthecotulide-type linear sesquiterpene lactones from Anthemis auriculata (2009) Phytomedicine, 16, pp. 783-787
• Katsila, T., Spyroulias, G.A., Patrinos, G.P., Computational approaches in target identification and drug discovery (2016) Comput Struct Biotechnol J, 14, pp. 177-184. , Review
• Kavanagh, K.L., Guo, K., Dunford, J.E., The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs (2006) Proc Natl Acad Sci, 103, pp. 7829-7834
• Kerr, I.D., Lee, J.H., Farady, C.J., Vinyl sulfones as antiparasitic agents and a structural basis for drug design (2009) J Biol Chem, 284, pp. 25697-25703
• Kerr, I.D., Wu, P., Marion-Tsukamaki, R., Crystal structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei (2010) PLoS Negl Trop Dis, 4, p. e701
• Lechuga, G.C., Borges, J.C., Calvet, C.M., Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi (2016) Int J Parasitol Drugs Drug Resist, 6, pp. 154-164
• Leroux, A.E., Krauth-Siegel, R.L., Thiol redox biology of trypanosomatids and potential targets for chemotherapy (2016) Mol Biochem Parasitol, 206, pp. 67-74
• Manta, B., Comini, M., Medeiros, A., Trypanothione: A unique bis-glutathionyl derivative in trypanosomatids (2013) Biochim Biophys Acta, 1830, pp. 3199-3216
• Maya, J.D., Cassels, B.K., Iturriaga-Vásquez, P., Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host (2007) Comp Biochem Physiol A Mol Integr Physiol, 146, pp. 601-620
• McCabe, R., Failure of ketoconazole to cure chronic murine Chagas' disease (1988) J Infect Dis, 158, pp. 1408-1409
• McCall, L.I., El Aroussi, A., Choi, J.Y., Targeting ergosterol biosynthesis in Leishmania donovani: Essentiality of sterol 14 alpha-demethylase (2015) PLoS Negl Trop Dis, 9, p. e0003588
• Merli, M.L., Pagura, L., Hernández, J., The Trypanosoma cruzi protein TcHTE is critical for heme uptake (2016) PLoS Negl Trop Dis, 10, p. e0004359
• Miller, B.R., Roitberg, A.E., Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis) (2013) Future Med Chem, 5, pp. 1889-1900
• Moreira, A.A., de Souza, H.B., Amato Neto, V., Evaluation of the therapeutic activity of itraconazole in chronic infections, experimental and human, by Trypanosoma cruzi (1992) Rev Inst Med Trop Sao Paulo, 34, pp. 177-180
• Mukherjee, S., Huang, C., Guerra, F., Thermodynamics of bisphosphonates binding to human bone: A two-site model (2009) J Am Chem Soc, 131, pp. 8374-8375
• Nowicki, M.W., Tulloch, L.B., Worralll, L., Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis (2008) Bioorg Med Chem, 16, pp. 5050-5061
• Paniz-Mondolfi, A.E., Pérez-Alvarez, A.M., Lanza, G., Amiodarone and itraconazole: A rational therapeutic approach for the treatment of chronic Chagas' disease (2009) Chemotherapy, 55, pp. 228-233
• Proto, W.R., Coombs, G.H., Mottram, J.C., Cell death in parasitic protozoa: Regulated or incidental (2013) Nat Rev Microbiol, 11, pp. 58-66
• Raviolo, M.A., Solana, M.E., Novoa, M.M., Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi (2013) Eur J Med Chem, 69, pp. 455-464
• Rodenko, B., van der Burg, A.M., Wanner, M.J., 2,N 6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities (2007) Antimicrob Agents Chemother, 51, pp. 3796-3802
• San Francisco, J., Barría, I., Gutiérrez, B., Decreased cruzipain and gp85/trans-sialidase family protein expression contributes to loss of Trypanosoma cruzi trypomastigote virulence (2017) Microbes Infect, 19, pp. 55-61
• Saúde-Guimarães, D.A., Perry, K.S., Raslan, D.S., Complete assignments of 1H and 13C NMR data for trypanocidal eremantholide C oxide derivatives (2007) Magn Reson Chem, 45, pp. 1084-1087
• Sbaraglini, M.L., Bellera, C.L., Fraccaroli, L., Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease (2016) Int J Antimicrob Agents, 48, pp. 91-95
• Schmidt, T.J., Brun, R., Willuhn, G., Anti-trypanosomal activity of helenalin and some structurally related sesquiterpene lactones (2002) Planta Med, 68, pp. 750-751
• Schmidt, T.J., Khalid, S.A., Romanha, A.J., The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I (2012) Curr Med Chem, 19, pp. 2128-2175
• Scory, S., Stierhof, Y.D., Caffrey, C.R., The cysteine proteinase inhibitor Z-Phe-Ala-CHN2 alters cell morphology and cell division activity of Trypanosoma brucei bloodstream forms in vivo (2007) Kinetoplastid Biol Dis, 6, p. 2
• Serrano-Martín, X., García-Marchan, Y., Fernandez, A., Amiodarone destabilizes intracellular Ca2+ homeostasis and biosynthesis of sterols in Leishmania mexicana (2009) Antimicrob Agents Chemother, 53, pp. 1403-1410
• Shang, N., Li, Q., Ko, T.P., Squalene synthase as target for Chagas disease therapeutics (2014) PLoS Pathog, 10, p. e1004114
• Silva-Jardim, I., Thiemann, O.H., de Anibal, F.F., Leishmaniasis and Chagas disease chemotherapy: A critical review (2014) J Braz Chem Soc, 25, pp. 1810-1823
• Smirlis, D., Duszenko, M., Ruiz, A.J., Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death (2010) Parasit Vectors, 3, p. 107. , Review
• Steenkamp, D.J., Thiol metabolism of the trypanosomatids as potential drug targets (2002) IUBMB Life, 53, pp. 243-248
• Sueth-Santiago, V., Moraes, J.B., Sobral Alves, E.S., The effectiveness of natural diaryl-heptanoids against Trypanosoma cruzi: Cytotoxicity, ultrastructural alterations and molecular modeling studies (2016) PLoS One, 11, p. e0162926
• Sueth-Santiago, V., Decote-Ricardo, D., Morrot, A., Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host (2017) World J Biol Chem, 8, pp. 57-80
• Sülsen, V.P., Frank, F.M., Cazorla, S.I., Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae) (2008) Antimicrob Agents Chemother, 52, pp. 2415-2419
• Sülsen, V.P., Frank, F.M., Cazorla, S.I., Psilostachyin C: A natural compound with trypanocidal activity (2011) Int J Antimicrob Agents, 37, pp. 536-543
• Sülsen, V.P., Cazorla, S.I., Frank, F.M., Natural terpenoids from Ambrosia species are active in vitro and in vivo against human pathogenic trypanosomatids (2013) PLoS Negl Trop Dis, 7, p. e2494
• Sülsen, V.P., Puente, V., Papademetrio, D., Mode of action of the sesquiterpene lactones psilostachyin and psilostachyin C on Trypanosoma cruzi (2016) PLoS One, 11, p. e0150526
• Tripodi, K.E., Menendez Bravo, S.M., Cricco, J.A., Role of heme and heme-proteins in try-panosomatid essential metabolic pathways (2011) Enzyme Res, 201, p. 873230
• Turrens, J.F., Oxidative stress and antioxidant defences: A target for the treatment of diseases caused by parasitic protozoa (2004) Mol Asp Med, 25, pp. 211-220
• Urbina, J.A., Specific treatment of Chagas disease: Current status and new developments (2001) Curr Opin Infect Dis, 14, pp. 733-741
• Urbina, J.A., Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches (2010) Acta Trop, 115, pp. 55-68
• Urbina, J.A., Concepcion, J.L., Caldera, A., In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi (2004) Antimicrob Agents Chemother, 48, pp. 2379-2387
• Vannier-Santos, M.A., Urbina, J.A., Martiny, A., Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania (1995) J Eukaryot Microbiol, 42, pp. 337-346
• Veiga-Santos, P., Barrias, E.S., Santos, J.F., Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi (2012) Int J Antimicrob Agents, 40, pp. 61-71
• Vieira, P.M., Francisco, A.F., Machado, E.M., Different infective forms trigger distinct immune response in experimental Chagas disease (2012) PLoS One, 7, p. e32912

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------